Researchers studied the effect of a second primary melanoma on overall survival among patients with a previous cutaneous or non-cutaneous melanoma.

HealthDay News — Commonly used noncancer medications, including proton pump inhibitors, are associated with poorer survival and adverse events for patients with breast cancer, according to a study ...

Cardiac testing identified asymptomatic, clinically significant arrhythmias in 19% of patients on ibrutinib.

Pemigatinib was well-tolerated among patients with CCA regardless of presence of CUP, but HCRU costs were higher with CUP vs without CUP.

Perioperative enfortumab vedotin and pembrolizumab added to surgery may represent a new standard of care in this population with a high unmet medical need,” said Christof Vulsteke, MD, PhD.

In this study, researchers examined associations between multiple primary cancer incidence and county-level smoking prevalence.

Supervised aerobic, resistance exercise tied to improved lean mass, muscle strength, and physical performance.

There was no significant difference in survival outcomes for patients with advanced neuroendocrine tumors who were treated with low-dose everolimus compared to standard-dose everolimus, according to a ...

Study researchers noted that the findings suggest the association between anxiety and improved OS was at least partly related to the higher incidence of irAEs, which implies that, in people with an ...

Findings showed both zanidatamab treatment arms demonstrated statistically significant and clinically meaningful improvements in PFS vs the SOC arm.

A review of EMR data from younger and older women with breast cancer noted that social support was not consistently documented among patients.

The treatment effects on PFS were consistent regardless of modeling approach and for both targeted and nontargeted therapies.